comparemela.com

Latest Breaking News On - Remus pharmaceuticals - Page 1 : comparemela.com

Ahead of Market: 10 things that will decide D-Street action on Wednesday

Benchmark equity indices recovered to close flat on Tuesday, with gains in metal stocks offsetting declines in other sectors following top consumer China s property-support measures.

China
India
Italy
Italian
Tejas-shah
Bharti-airtel
Anupam-rasayan
Subash-gangadharan
Bank-rs
Solar-industries-india
Remus-pharmaceuticals
Tejas-networks

Remus Pharma zooms 20% to life high after declaring bonus issue of shares

SME listed stocks are seen outperforming the key benchmark indices in CY24 even after SEBI cautioned about possibilities of some froth in small caps and SME market segment.

Remus-pharma
Remus-pharmaceuticals

2023 in Review: 62 of 176 SMEs listed this year have delivered multibagger returns; details here

234 companies have raised funds from Indian markets so far in 2023, with a significant portion of 176 companies falling within the SME category. In comparison, CY22 witnessed 103 SMEs entering the market; the number was 52 in 2021, 31 in 2020, and 31 in 2019.

Deepak-chemtex
Exhicon-events-media-solutions
Remus-pharmaceuticals
Siyaram-recycling-industries
Company-shipping-agencies
Kahan-packaging-solutions
Anlon-technology-solutions-srivari-spices
Krishca-strapping-solutions
Qinfra-solutions
Motisons-jewellers
Gayatri-rubbers
Meson-valves

IPOs: SME platform seeing flurry of listing action

So far, in 2023, 100 SME firms have raised a record ₹2,600 crore of funds from the SME board, breaking the previous record of ₹2,287 crore raised in 2018 by 141 firms. By contrast, 19 companies have raised around ₹14,500 crore on the main board

Mumbai
Maharashtra
India
Brijesh-parekh
Infinium-pharmachem
Mahavir-lunawat
Exhicon-events-media-solutions
Pantomath-financial-services-group
Remus-pharmaceuticals-srivasavi-adhesive-tapes
Anlon-technology-solutions
Krishca-strapping-solutions
Oriana-power

SME Platform Seeing Flurry of Listing Action

A trading platform dedicated to small and medium enterprises (SMEs) is currently witnessing a flood of public offerings on surging demand from rich individual domestic investors with the risk appetite for such small issuances.

India
Brijesh-parekh
Mahavir-lunawat
Infinium-pharmachem
Exhicon-events-media-solutions
Pantomath-financial-services-group
Remus-pharmaceuticals-srivasavi-adhesive-tapes
Anlon-technology-solutions
Krishca-strapping-solutions
Oriana-power
Pantomath-financial-services
Drone-destinations

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.